Phibro Animal Health Corporation (PAHC)
Company Info
US71742Q1067
71742Q106
Apr 11, 2014
Highlights
$747.73M
$0.48
38.40
1.66
$842.86M
$272.14M
$77.58M
$16.02 - $26.42
$18.00
6.05%
3.93
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Phibro Animal Health Corporation (PAHC) returned 7.54% year-to-date (YTD) and 29.91% over the past 12 months. Over the past 10 years, PAHC returned -2.81% annually, underperforming the S&P 500 benchmark at 10.45%.
PAHC
7.54%
17.89%
-4.83%
29.91%
2.67%
-2.81%
^GSPC (Benchmark)
-3.77%
3.72%
-5.60%
8.55%
14.11%
10.45%
Monthly Returns
The table below presents the monthly returns of PAHC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.86% | 4.26% | -5.60% | -12.87% | 20.74% | 7.54% | |||||||
| 2024 | -6.65% | 19.61% | 0.88% | 29.16% | 5.57% | -4.21% | 12.58% | 11.23% | 7.89% | 2.66% | 1.60% | -10.14% | 86.29% |
| 2023 | 14.84% | 2.79% | -2.48% | 1.57% | -14.52% | 3.95% | 5.69% | -3.66% | -7.63% | -14.49% | -11.15% | 20.75% | -10.36% |
| 2022 | -5.48% | 10.36% | -5.81% | -9.82% | 7.45% | -0.42% | 2.30% | -24.32% | -9.52% | 10.53% | -15.36% | 8.94% | -32.32% |
| 2021 | 6.80% | 4.00% | 13.72% | 0.49% | 14.97% | 2.89% | -18.04% | 3.14% | -11.32% | 1.86% | -10.23% | 4.24% | 7.28% |
| 2020 | -4.47% | 6.45% | -3.82% | 10.51% | -1.91% | 0.74% | -11.71% | -7.48% | -18.46% | -5.52% | 15.65% | 2.81% | -20.09% |
| 2019 | -2.92% | -6.15% | 13.10% | 5.18% | -14.78% | 7.84% | -2.01% | -33.67% | 3.90% | 12.33% | 1.76% | 2.35% | -21.30% |
| 2018 | 1.64% | 12.92% | 3.51% | 6.55% | 6.86% | 2.10% | 4.02% | -1.46% | -8.92% | 0.05% | -20.73% | -5.13% | -3.00% |
| 2017 | -8.87% | 4.67% | 0.90% | 5.87% | 18.83% | 5.11% | 3.10% | -7.07% | 4.66% | 1.62% | -7.84% | -3.16% | 15.74% |
| 2016 | 11.35% | -17.26% | -2.24% | -23.30% | -7.96% | -1.74% | 10.56% | 17.64% | 12.43% | -4.53% | 6.16% | 6.74% | -1.16% |
| 2015 | -13.38% | 32.71% | -2.10% | -10.31% | 9.04% | 12.77% | 0.87% | -9.88% | -10.40% | 5.47% | -2.38% | -7.21% | -3.40% |
| 2014 | 3.88% | 7.76% | 15.34% | -13.62% | 1.48% | 17.08% | 15.66% | 17.90% | 3.58% | 87.18% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 76, PAHC is among the top 24% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Phibro Animal Health Corporation provided a 2.14% dividend yield over the last twelve months, with an annual payout of $0.48 per share. The company has been increasing its dividends for 10 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | $0.42 | $0.40 | $0.40 | $0.40 | $0.20 |
Dividend yield | 2.14% | 2.29% | 4.15% | 3.58% | 2.35% | 2.47% | 1.93% | 1.31% | 1.19% | 1.37% | 1.33% | 0.63% |
Monthly Dividends
The table displays the monthly dividend distributions for Phibro Animal Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | |||||||
| 2024 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2023 | $0.00 | $0.12 | $0.00 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2022 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2021 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2020 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2019 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2018 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.12 | $0.00 | $0.42 |
| 2017 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.40 |
| 2016 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.00 | $0.10 | $0.00 | $0.10 | $0.00 | $0.40 |
| 2015 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.40 |
| 2014 | $0.10 | $0.00 | $0.00 | $0.00 | $0.10 | $0.20 |
Dividend Yield & Payout
Dividend Yield
Phibro Animal Health Corporation has a dividend yield of 2.14%, which is quite average when compared to the overall market.
Payout Ratio
Phibro Animal Health Corporation has a payout ratio of 29.81%, which is quite average when compared to the overall market. This suggests that Phibro Animal Health Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Phibro Animal Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Phibro Animal Health Corporation was 79.60%, occurring on Nov 10, 2023. The portfolio has not yet recovered.
The current Phibro Animal Health Corporation drawdown is 50.43%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -79.6% | Aug 28, 2018 | 1311 | Nov 10, 2023 | — | — | — |
| -54.8% | Aug 12, 2015 | 193 | May 17, 2016 | 305 | Aug 2, 2017 | 498 |
| -21.85% | Jun 12, 2014 | 40 | Aug 7, 2014 | 45 | Oct 10, 2014 | 85 |
| -19.03% | Aug 18, 2017 | 117 | Feb 5, 2018 | 19 | Mar 5, 2018 | 136 |
| -17.16% | Dec 9, 2014 | 36 | Jan 30, 2015 | 11 | Feb 17, 2015 | 47 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Phibro Animal Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Phibro Animal Health Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 19.2% positive surprise.
Valuation
The Valuation section provides an overview of how Phibro Animal Health Corporation is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PAHC, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/E ratio of 38.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PAHC compared to other companies in the Drug Manufacturers - Specialty & Generic industry. PAHC currently has a PEG ratio of 1.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PAHC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PAHC in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/B value of 3.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |